We assign a fundamental rating of 2 out of 10 to LTRN. LTRN was compared to 525 industry peers in the Biotechnology industry. While LTRN seems to be doing ok healthwise, there are quite some concerns on its profitability. LTRN has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

LTRN had negative earnings in the past year.
LTRN had a negative operating cash flow in the past year.
In the past 5 years LTRN always reported negative net income.
In the past 5 years LTRN always reported negative operating cash flow.

1.2 Ratios

LTRN has a worse Return On Assets (-138.85%) than 82.86% of its industry peers.
Looking at the Return On Equity, with a value of -197.36%, LTRN is doing worse than 67.81% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-138.85%
ROE	-197.36%
ROIC	N/A

ROA(3y)-47.36%

ROA(5y)-37.56%

ROE(3y)-54.18%

ROE(5y)-41.96%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

LTRN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LTRN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, LTRN has more shares outstanding
There is no outstanding debt for LTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -7.92, we must say that LTRN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.92, LTRN is doing worse than 66.86% of the companies in the same industry.
LTRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-7.92

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 3.33 indicates that LTRN has no problem at all paying its short term obligations.
LTRN has a Current ratio (3.33) which is comparable to the rest of the industry.
LTRN has a Quick Ratio of 3.33. This indicates that LTRN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.33, LTRN is in line with its industry, outperforming 42.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.33
Quick Ratio	3.33

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LTRN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.69%.

EPS 1Y (TTM)1.69%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%7.14%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, LTRN will show a decrease in Earnings Per Share. The EPS will decrease by -3.06% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y11.74%

EPS Next 2Y-0.47%

EPS Next 3Y-2.2%

EPS Next 5Y-3.06%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LTRN. In the last year negative earnings were reported.
Also next year LTRN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.